All In Biotech

Drug Trial Radar · NCT06653842

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations

Last checked: Nov 19, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Dec 20, 2024

Primary completion

Nov 21, 2025

Study completion Mar 2026

Sponsor

Lead sponsor
Palvella Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Oct 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX022 (sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations

Conditions

  • Cutaneous Venous Malformations

Interventions

  • QTORIN 3.9% rapamycin anhydrous gelDrug

    QTORIN 3.9% Rapamycin Anhydrous Gel

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-Emergent Adverse EventsTime frame: Week 12

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital of Orange County

    Irvine, California

  • Stanford University

    Palo Alto, California

  • Colorado Children's Hospital

    Aurora, Colorado

  • Johns Hopkins

    Baltimore, Maryland

  • Minnesota Clinical Study Center

    New Brighton, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • University of North Carolina

    Chapel Hill, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • University of Utah Health

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.